Zafgen, Inc. (ZFGN)
(Delayed Data from NSDQ)
$2.65 USD
+0.09 (3.52%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.65 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.65 USD
+0.09 (3.52%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.65 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News
by Zacks Equity Research
Key highlights of the past week are regulatory and pipeline developments.
Zafgen Enters Oversold Territory
by Zacks Equity Research
Zafgen, Inc. (ZFGN) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Biotech Stock Roundup: Pipeline Updates From CELG & VRTX, ZFGN Plunges on Hold News
by Zacks Equity Research
Pipeline and regulatory updates are the key highlights in the biotech sector this week.
Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial
by Zacks Equity Research
Zafgen's (ZFGN) stock plunges significantly as the FDA placed a clinical hold on the company's first trial on experimental diabetes drug, ZGN-1061.
Company News For Nov 27, 2018
by Zacks Equity Research
Companies In The News Are: ZFGN,CLF,AET,CVS,GWPH
Zafgen (ZFGN) Surges: Stock Moves 9.2% Higher
by Zacks Equity Research
Zafgen (ZFGN) shares rose more than 9% in the last trading session, amid huge volumes.